Published in Vaccine Weekly, October 22nd, 2003
According to published research from the United States, "Although the smallpox virus was eradicated over 20 years ago, its potential release through bioterrorism has generated renewed interest in vaccination. To develop a modern smallpox vaccine, we have adapted vaccinia virus that was derived from the existing Dryvax vaccine for growth in a human diploid cell line."
"We characterized six cloned and one uncloned vaccine candidates," reported Richard Weltzin and collaborators at Acambis Inc., PRA International, and the University of Massachusetts. "One clone, designated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly